Results 121 to 130 of about 35,394 (206)

Complete response of somatic <i>POLE</i>-ultramutated recurrent undifferentiated uterine sarcoma to pembrolizumab and concurrent radiotherapy. [PDF]

Gynecol Oncol Rep
Charewycz NE, Hsu IJ, Lu K, Fuh K, Chen LM, Monga V, Cham S.   +6 more
europepmc   +1 more source

Prognostic Factors and Role of Pelvic Lymphadenectomy in Patients with Uterine Sarcoma: A Multi-Center Population-Based Cohort Study. [PDF]

Int J Womens Health
Zhuo Y, Ji W, Cheng X.
europepmc   +1 more source

High visceral-to-subcutaneous fat area ratio is an unfavorable prognostic indicator in patients with uterine sarcoma. [PDF]

Jpn J Radiol
Kurokawa M, Gonoi W, Hanaoka S, Kurokawa R, Uehara S, Kato M, Suzuki M, Toyohara Y, Takaki Y, Kusakabe M, Kino N, Tsukazaki T, Unno T, Sone K, Abe O.   +14 more
europepmc   +1 more source

Retraction: FGF23 is a potential prognostic biomarker in uterine sarcoma. [PDF]

Technol Cancer Res Treat
europepmc   +1 more source

Development and external validation of a nomogram for choosing postoperative adjuvant therapies in uterine sarcoma patients using real-world data. [PDF]

Front Oncol
Li L, Tao W, Ouyang Z.
europepmc   +1 more source

Advancement in Multi-omics approaches for Uterine Sarcoma. [PDF]

Biomark Res
Wang W, Hu Y, Fu F, Ren W, Wang T, Wang S, Li Y.   +6 more
europepmc   +1 more source

Management and prognosis of uterine sarcoma in elderly. [PDF]

Gynecol Pelvic Med
Gorostidi M, Romero V, Yildirim Y, Macuks R, Mancari R, Achimas-Cadariu P, Muruzabal JC, Coronado PJ, Gardella B, Zapardiel I.   +9 more
europepmc   +1 more source

Survival guided adaptive clustering enhances mortality risk stratification and radiotherapy guidance in early stage uterine sarcoma. [PDF]

Sci Rep
Zhou X, Yuan S, Li T, Zhang T, Wang W, Zhu X.   +5 more
europepmc   +1 more source

Facilitation of natural killer T-cell cytotoxic activity in uterine sarcoma via the <i>CKS2-PI3K-AKT-MICA</i> axis. [PDF]

Transl Cancer Res
Du Y, Lan T, Liu M, Wu W, Ma J.
europepmc   +1 more source

Local control of locally advanced uterine sarcoma achieved by cervical brachytherapy with gel spacer following cyclic hypofractionated radiation therapy (QUAD shot) in a patient who refused surgery. [PDF]

BJR Case Rep
Kosugi Y, Murakami N, Karino T, Muramoto Y, Kawamoto T, Oshima M, Okonogi N, Saito AI, Takatsu J, Inoue T, Iijima K, Hashizume A, Tomita S, Kato M, Ujihira T, Makino S, Hirayama T, Fujino K, Terao Y, Shikama N.   +19 more
europepmc   +1 more source